Eighteen (1-18) and seven (1, 4, 6-8, 17 and 18) compounds were isolated from organic extracts of axenic cultures of two freshwater fungi Clohesyomyces sp. and Clohesyomyces aquaticus (Dothideomycetes, Ascomycota), respectively. Compounds 1-12 belong to the α-pyrone class of natural products, compounds 13 and 14 were tetrahydroxanthones, compounds 15 and 16 were hexahydroxanthones, while compounds 17 and 18 were cyclodepsipeptides. The structures were elucidated using a set of spectroscopic and spectrometric techniques. The absolute configurations of compounds 2, 3, 6, and 7 were assigned via a modified Mosher's ester method using 1 H NMR data. The relative configurations of compounds 14-16 were determined through NOE data. Compounds 1, 2, 6, 8, 13, 14 , and 15 were found to inhibit the essential enzyme bacterial peptidyl-tRNA hydrolase (Pth1), with (13; secalonic acid A) being the most potent. Compounds 1 and 4-18 were also evaluated for antimicrobial activity against an array of bacteria and fungi but were found to be inactive.
Introduction
In pursuit of structurally unique and bioactive secondary metabolites from distinct ecological habitats, our group has been interested in fungi, particularly freshwater fungi 1, 2, 3, 4, 5 that inhabit submerged woody and herbaceous substrates in streams and lakes. 6 Freshwater fungi represent a potentially rich, although poorly studied, source of new mycological and chemical diversity.
While working in the Lake Brandt watershed of Greensboro, NC, two related freshwater fungal species, belonging to the genus Clohesyomyces, were isolated from submerged wood and accessioned as G100 and G102. Fungal strain G102 biosynthesized 18 compounds belonging to three distinct classes of natural products. Twelve were members of the α-pyrone class of secondary metabolites (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , of which five were known [phomopsinone A (1), phomopsinone B (2), phomopsinone C (3), pyrenocine M (4), and pyrenocine K (5)] and seven were new [6- hydroxy-7-epi-phomopsinone A (6), 5-deoxy-7-hyrdoxypyrenocine M (7), pyrenocine P (8), 7-hyrdoxypyrenocine M (9), pyrenocine Q (10), pyrenocine R (11), 5-hydroxyphomopsinone A (12) ]. Alternatively, four metabolites were tetra/hexahydroxanthones (13) (14) (15) (16) , of which one was the known homodimeric tetrahydroxanthone, secalonic acid A (13), another was a new natural monomeric tetrahydroxanthone [8-hydroxyblennolide H (14) ], and two were new monomeric hexahydroxanthones [cis-dihydro-8-hydroxyblennolide H (15) and trans-dihydro-8-hydroxyblennolide H (16) ]. Finally, also isolated were the two known cyclodepsipeptides [Sch 378161 (17) and Sch 217048 (18) ]. From the perspective of chemical mycology, it was interesting that of these 18 metabolites, the related strain G100 biosynthesized seven overlapping compounds, being 1, 4, 6-8, 17 and 18, which belong to the α-pyrone and cyclodepsipeptide classes of compounds, while the tetra/hexahydroxanthones were biosynthesized only by the G102 strain. Since these related fungi were isolated from the same freshwater habitat, and because they biosynthesized an overlapping series of compounds, the chemical, biological, and mycological data were combined into a single communication.
α-Pyrones have been reported to have varying potency in assays for antifungal, antibacterial, and antialgal activity. 9, 10 Tetrahydroxanthones are an important class of mycotoxins with diverse biological activities, including antitumor, antibacterial, and anti-HIV. 11, 12, 13, 14, 15, 16, 17 The isolated cyclodepsipeptides in this study were reported as selective and competitive human tachykinin receptor (NK2) antagonists. 18 Given this diversity of biological activities, compounds 1-18 were evaluated against a panel of bacteria and fungi. While in vivo activity was without prospect, in vitro inhibitory activity against the essential enzyme bacterial peptidyltRNA hydrolase (Pth1) was observed. Bacterial Pth1 represents a promising new target for antibiotic development 19 for which little is known about small molecule inhibition. 20 Based on this initial screening set, secondary metabolites from fungal cultures could serve as a source of Pth1 inhibitors, providing avenues to better understand inhibitor binding and inhibitor bound states.
Results and discussion
The freshwater fungal strains, coded G100 and G102, were ITS sequenced 21 and identified as Clohesyomyces aquaticus (Dothideomycetes, Ascomycota) and Clohesyomyces sp., respectively. Large-scale solid-phase cultures of G100 and G102 were extracted and partitioned with organic solvents, as described previously. 3, 5 The organic extracts were then purified separately using normal-phase flash chromatography to generate five fractions each, which were then subjected to further purifications using preparative and semipreparative HPLC to yield seven (1, 4, 6-8, 17 and 18) and 18 compounds (1-18) from G100 and G102, respectively; all compounds were verified to have >95% purity as measured by UPLC using an evaporative light scattering detector (ELSD) (Fig. S1 , Supporting Information). The biosynthetic potential of these two fungal cultures was broad, as compounds 1-12 belonged to the α-pyrone class of natural products, compounds 13-16were tetra/hexahydroxanthones, while compounds 17 and 18 were cyclodepsipeptides. Fig. 1 . Structures of metabolites isolated from fungal cultures G100 and G102 (1-18).
α-Pyrone derivatives
The NMR and HRESIMS, along with CD and optical rotation data, where appropriate, identified compounds 1 [6.1 mg (G100); 27.8 mg (G102)]; 2 [0.8 mg (G102)], 3 [0.7 mg (G102)], 4 [0.8 mg (G100); 1.7 mg (G102)], and 5 [0.5 mg (G102)] as the known metabolites phomopsinone A, 10 phomopsinone B, 10 phomopsinone C, 10 pyrenocine M, 9 and pyrenocine K, 9 respectively (Figs. 1 and S2-S6, Table S1 ). Compounds 1 and 4 were first isolated from two different strains of an endophytic Phomopsis sp., which were isolated from two different plant hosts. 9, 10 The specific rotation data of 1 was not reported previously and hence provided herein. Epimeric 2 and 3 were first isolated from an endophytic Phomopsis sp., which was isolated from Santolina chamaecyparissus. 10 The absolute configuration of 2 was determined by CD spectroscopy and TDDFT calculations. 10 However, due to paucity and insufficient purity of 3, the researchers were unable to collect CD data to assign the absolute configuration. Hence, they relied on biogenetic considerations and the fact that 2 and 3 were epimers at C-10 to propose the absolute configuration for 3. No specific rotation data were reported for compounds 2 and 3. Herein, the absolute configurations of 2 and 3 were confirmed via a modified Mosher's ester method (Fig. 2) , 22 the specific rotation data for 2 and 3 and the CD data for 3 were provided as well (Fig. 3) . Finally, compound 5 was identified as the known pyrenocine K, which was first isolated from a Phomopsis sp., an endophyte of Cistus salviifolius. 9 There were some minor differences between the reported and the collected NMR data for 5 (Table S2) ; however the 2D-NMR and specific rotation data confirmed the structure of 5 as the known pyrenocine K. 9 The NMR data are provided to update the literature (Table 1) . CD data have not been reported for compound 5 and hence they are provided (Fig. 3) to confirm the absolute configuration as 7R. In short, the characterization data for five of the previously reported α-pyrones have been refined. respectively of phomopsinone B (2), B) 3a and 3b, respectively of phomopsinone C (3), C) 6a and 6b, respectively of 6-hydroxy-7-epi-phomopsinone A (6), and D) 7a and 7b, respectively of 5-deoxy-7-hyrdoxypyrenocine M (7) in pyridine-d5.
Compound 6 [2.0 mg (G100); 1.2 mg (G102)] was obtained as a colorless solid with a molecular formula of C12H16O5 as determined by HRESIMS along with 1 H, 13 C, and edited-HSQC NMR data (Table 1, Table 2 , Fig. S7 ), establishing an index of hydrogen deficiency of 5. The NMR data suggested that 6 was an α-pyrone analogue of 1. A key difference was replacement of the allylic methylene moiety (δH/δC 2.40/32.5, dd, J = 6.4, 1.8 for H2-6/C-6) in 1 by an oxymethine in 6 (δH/δC 4.21/66.6, dddd, J = 7.9, 2.9, 2.3, 1.7 for H-6/C-6). These data, along with a 16 amu difference in the HRMS data of compounds 1 and 6, indicated hydroxylation at the C-6 position in 6. The coupling constant (JH-6/H-7 = 7.9 Hz) implied a pseudoaxial/pseudoequatorial cis orientation in 6 ( Table 1, Fig. S7 ). NOESY correlations observed between H-6 and H-7 indicated that these two protons were on the same face (Fig. 4 ). An HMBC correlation was observed from 11-OCH3 to C-4, indicating the connectivity of the methoxy group (Fig. 5) . HMBC correlations from H-3 to C-4, C-4a, and C-2, from H2-5 to C-6a and C-7, from H-6 to C-4a and C-8, from H-7 to C-9, and from H3-10 to C-8 were observed (Fig. 5) . The trivial name 6-hydroxy-7-epiphomopsinone A was ascribed to compound 6. The absolute configuration of 6 was assigned via a modified Mosher's ester method, 22 establishing the configurations as 6S and 7R (Fig. 2C ), which were opposite to that reported for the known phomopsinone D. 10 Moreover, 6-hydroxy-7-epi-phomopsinone A (6) and phomopsinone D showed opposite CD spectra (Table S1, Fig. 3 ).
The specific rotation data for phomopsinone D have not been reported in the literature previously. Compound 8 [2.5 mg (G100); 2.4 mg (G102)] was obtained as a colorless solid with a molecular formula of C10H12O5 as determined by HRESIMS along with 1 H, 13 C, and edited-HSQC NMR data (Table 1, Table 2 , Fig. S9 ), establishing an index of hydrogen deficiency of 5. These NMR data suggested 8 as an α-pyrone derivative with structural similarity to 1. Key differences were observed in the aliphatic side chain, where the terminal ethyl moiety in 1 was replaced by a hydroxy group in 8. These considerations, along with the COSY and HMBC data, established the structure of 8 (Fig. 5) , which was confirmed via single crystal X-ray diffraction (Fig. 6) ; ECD data suggested the absolute configuration as 7S. The trivial name pyrenocine P was ascribed to compound 8. Compound 9 [6.9 mg (G102)], which was also obtained as a colorless solid, was found to have a molecular formula of C12H18O5 as determined by HRESIMS along with 1 H, 4. The structure of 9 was determined as an α-pyrone derivative by comparison of its NMR and HRMS data with those of 4. A key difference was replacement of the methylene moiety (δH/δC 1.68/27.9, m, H2-7/C-7) in 4 by an oxymethine in 9 (δH/δC4.01/69.2, m, for H-7/C-7). These data, along with a 16 amu difference in the HRMS data of compounds 4 and 9, indicated hydroxylation at C-7 in 9. HMBC correlations from H-3 to C-4, C-4a, and C-2, from H2-5 to C6a and C-4, from H2-6 to C-4a and C-8, from H2-9 to C-7, and from H3-10 to C-8 were observed (Fig. 5) . The trivial name 7-hyrdoxypyrenocine M was ascribed to compound 9. In an attempt to determine the absolute configuration of 9 via a modified Mosher's ester method, 22 the compound was found to be racemic, suggesting that it may be an artifact of the purification processes (Fig.  S10B ).
Compound 10 [0.7 mg (G102)] was obtained as a colorless solid with a molecular formula of C12H18O4 as determined by HRESIMS and analysis of 1 H, 13 C, and edited-HSQC NMR data ( Table 2, Table 3 , Fig. S11 ). Inspection of the NMR data suggested compound 10 as an α-pyrone analogue with structural similarity to 7, both sharing the same molecular formula. However, the allylic methyl singlet (δH/δC 1.90/9.71, s, for H3-5/C-5) in 7 was replaced by an olefinic proton (δH/δC 6.34/92.9, s, for H-4a/C-4a) in 10, and the olefinic proton (δH/δC 5.46/88.1, s, for H-3/C-3) in 7 was replaced by an allylic methyl singlet (δH/δC1.90/8.8, s, for H3-5/C-5) in 10. These data indicated that the olefinic proton and the methyl group switched positions, which was confirmed by observed HMBC correlations from H-4a to C-6 and C-6a (Fig. 5 ). Another key difference included a 1,2-hydroxy shift in 10 relative to 7. The allylic methylene moiety (δH/δH/δC 2.62/2.69/38.9, dd, J = 14.3, 4.0 and J = 14.3, 8.6, for H-6a/H-6b/C-6, respectively) in 7 was replaced by an allylic carbinol carbon (δH/δC4.42/71.4, m, for H-6/C-6), while the carbinol carbon (δH/δC 4.07/69.8, m, for H-7/C-7) in 7was replaced by a methylene moiety (δH/δH/δC 1.70/1.87/35.5, m, for H-7a/H-7b/C-7). This shift was confirmed by the observed HMBC correlations from 6-OH to C-6a and C-7, from H2-9 to C-7, and from H-6 to C-8 ( Fig. 5 ). Further examination of the NMR data, including COSY and HMBC spectra (Fig. 5) , yielded the structure of 10, which was ascribed the trivial name pyrenocine Q. As for 9, an attempt to determine the absolute configuration of 10 via a modified Mosher's ester method 22 revealed a racemic mixture of the R and Senantiomers.
Compound 11 [0.5 mg (G102)] was isolated as a colorless solid with a molecular formula of C8H10O4 as revealed by analysis of the HRESIMS, 1 H NMR, 13 C NMR and edited-HSQC NMR data ( Table 2, Table 3 , Fig. S12 ), indicating an index of hydrogen deficiency of four. Inspection of the NMR data indicated 11 was a relatively simple α-pyrone derivative, but with differences in the aliphatic side chain and the 3,6-dihydropyran ring. In addition to key NMR resonances for the α-pyrone ring, NMR data indicated the presence of a methoxy group, an allylic methyl singlet and an allylic hydroxymethyl group (Table 2, Table 3 , Fig. S12 ). These data suggested a trisubstituted α-pyrone derivative. HMBC correlations from H2-6 to C-4a, from H3-5 to C-6a, from H3-7 to C-4, and from H-3 to C-4a confirmed the substituents' positions (Fig. 5 ). Further examination of the NMR data yielded the structure of 11, which was ascribed the trivial name pyrenocine R.
Compound 12 [0.9 mg (G102)], which was isolated as a colorless solid, had a molecular formula of C12H16O5 as deduced from HRESIMS along with 1 H NMR, 13 C NMR, and edited-HSQC NMR data (Table 1, Table 3 , Fig. S13 ), indicating an index of hydrogen deficiency of 5.
Analysis of the NMR data indicated 12 as an α-pyrone derivative with structural similarity to 1. A key difference was replacement of the allylic oxymethylene moiety (δH/δH/δC 4.30/4.57/61.7, dt, J = 14.9, 2.9; d, J = 14.9, for H-5a/H-5b/C-5) in 1 by a dioxymethine group in 12 (δH/δC 5.87/87.4, d, J = 4.0, for H-5/C-5). These data, along with a 16 amu difference in the HRMS data of compounds 1 and 6, indicated hydroxylation at the C-5 position in 12, which was further confirmed by observation of an NMR signal for the -OH group (δH 2.81, d, J = 4.0) that showed diagnostic HMBC correlations with C-5 and C-4a (Table 3 , Fig. 5 ). Further analysis of the NMR spectra, including COSY and HMBC data, yielded the structure of 12, which was given the trivial name 5-hydroxyphomopsinone A. The similarity of the ECD data of 12 ( Fig. 3) with that of 1 (Fig. S2) , along with the observed NOESY correlation from 5-OH to H-7, were used to establish the absolute configuration as 5R and 7S (Fig. 4 ).
Monomeric/dimeric tetra/hexahydroxanthones
Compounds 13-16 were identified as a homodimeric tetrahydroxanthone (13), a monomeric tetrahydroxanthone (14) , and a pair of monomeric hexahydroxanthones (15) (16) . Analysis of HRMS, NMR, and ECD data identified 13 [7. 4 mg (G102)] as the known secalonic acid A (Figs. S2 and S14). 17, 23 Structurally related monomeric/dimeric tetrahydroxanthones, including 13, were isolated previously in our lab from an organic extract of the filamentous fungal culture Setophoma terrestris. Fig. S15 ), indicating an index of hydrogen deficiency of 9. Analysis of the HRMS and NMR data suggested 14 as a tetrahydroxanthone derivative with structural similarity to the monomeric units of 13. However, a key difference was replacement of the C-2 quaternary carbon in 13 (δC 118.3) by an aromatic methine in 14 (δH/δC 6.52/110.9, d, J = 8.0). COSY data identified two spin systems as H-2/H-3/H-4 and H-5/H-6/H2-7 (Fig. 5) . Further examination of the NMR spectra, including HMBC data (Fig. 5) , yielded the gross structure of 14, which was identical to the monomeric units of 13. A NOESY correlation was observed between 11-CH3 and H-5, indicating that those protons were on the same side of the molecule (Fig. 4) . A proton doublet corresponding to H-5 (δH 3.90, d, J = 10.9 Hz) implied a pseudodiaxial trans orientation of H-5/H-6, as observed in the monomeric units of 13. 17 These data along with biogenetic considerations established the relative configuration of 14 to be (5S,6R,10aS), the same as that of the monomeric units of 13. Due to the structural similarity of 14 with blennolide H, a tetrahydroxanthone derivative that has been recently isolated in our lab, 17 compound 14 was ascribed the trivial name 8-hydroxyblennolide H. Moreover, compound 14 and blennolide H showed similar ECD spectra (Fig. S2) , confirming the assignment of absolute configuration. Compound 14 was reported recently by synthesis and was described using the name (−)-blennolide B.
17
24 (−)-Blennolide B is an enantiomer of the natural blennolide B (which is dextro rotatory). 25 Due to this confusion with the trivial name, and because this is the first isolation of the natural product, we believe that 10-hydroxyblennolide H is a more appropriate and understandable name.
Cyclodepsipeptides
In addition to compounds 1-16, two known cyclodepsipeptides, Sch 378161 (17) [4.6 mg (G100); 1.4 mg (G102)] and Sch 217048 (18) [10.7 mg (G100); 1.6 mg (G102)], were isolated and identified by means of NMR and HRMS and MS/MS data (Fig. S18) , all of which compared favorably to the literature. 18, 26 2.4. Antimicrobial activity Compounds 1 and 4-18 were tested for antimicrobial activity against an array of bacteria and fungi (Staphylococcus aureus, Escherichia coli, Mycobacterium smegmatis, Candida albicans, and Aspergillus niger), but were found inactive. Compounds 1, 2, 6, 8, 13, 14, and 15 showed varying degrees of in vitro inhibition against bacterial Pth1 from several species. All but the most potent inhibitor lead to a decreased solubility of the enzyme under the conditions tested. A cloudiness in the reaction appeared upon addition of these compounds and was determined to be insoluble Pth1 from coomassie gel of the pelleted material after centrifugation. The degree of Pth1 aggregation was somewhat correlated to the amount of compound added, but also was effected by speed of compound addition, concentration of compound addition, temperature of the reaction, and was partially reversible over the course of the assay. Thus, while these compounds do appear to interact with Pth1, no meaningful quantitation of inhibition was possible. The most potent inhibitor was 13, demonstrating an IC50 of 1.4 mM against Salmonella typhimurium Pth1 (Fig. 7) . From chemical shift perturbation mapping, 13 was confirmed to bind in the active site (Fig. 8) . Helping to explain the low affinity, 13 also bound to at least one other site on Pth1, in part the same secondary site which did not affect enzyme activity for a previously reported synthetic inhibitor. 20 While not promising for clinical application, these findings represent the first reported small molecule natural product inhibitor of bacterial Pth1, which to date has been limited to crude natural product extracts. 27, 28 Therefore these compounds provide tools to expand our understanding of Pth1 inhibition. With the tremendous structural biology knowledge of apo Pth1, having an inhibitor enables an array of follow-up structure-function studies, far out weighing the lack of potency. Of particular interest is high resolution structural characterization of an inhibitor bound complex, providing understanding of small molecule Pth1 inhibition, for which there is no substrate or inhibitor bound complex known to date. Also, having inhibitors with known structures provides a means to help bridge the gap between computational docking and empirical inhibition. 1 H-15 N Chemical shift perturbations caused by 13 (secalonic acid A) binding to E. coli Pth1. At top, the ribbon diagram of E. coli Pth1 indicates residues with chemical shift perturbations between one third and one peak width in cyan and those greater than the peak width in blue. Catalytically essential His20 is red, with the side chain in the active site cleft shown. Below, the corresponding surface representations of Pth1 are colored as in part A. The cluster of perturbed residues (black arrow) indicate an interaction distinct from the Pth1 active site.
Conclusions
From two fungal cultures that were isolated from submerged wood in a lake, 18 compounds (1-18) belonging to three structural classes, α-pyrone, tetra/hexahydroxanthones, and cyclodepsipeptides, were isolated and characterized. The studied fungi, G100 and G102, shared the ability to biosynthesize two classes of natural products, α-pyrone and cyclodepsipeptides. On the other hand, G102 has the additional biosynthetic capabilities to generate tetrahydroxanthone derivatives. The absolute configuration of the known (2 and 3) and the new (6 and 7) α-pyrone derivatives were assigned via a modified Mosher's ester method. The relative configurations of the tetra/hexahydroxanthones (14-16) were determined through NOE data. Via testing these compounds against a new assay for inhibition of bacterial Pth1, 30 the first natural product inhibitor (13) for this potential antibiotic target was identified. While target based screening for antibacterials has many well documented challenges, 31 identification of Pth1 inhibitors opens the possibility for characterization of an inhibitor bound complex, which may, in turn, lead to more meaningful use of computational aspects aimed at inhibitor design/development. Interestingly, the dimeric tetrahydroxantione class of compounds, such as 13, seems to be attracting interest of the synthetic community. 24 The current study is another demonstration 4 that understudied biodiversity, regardless of its proximity to urban vs rural vs extreme locations, often reveals new chemical diversity.
Experimental

General experimental procedures
Optical rotations, UV data, and ECD spectra were obtained using a Rudolph Research Autopol III polarimeter (Rudolph Research Analytical), a Varian Cary 100 Bio UV-vis spectrophotometer (Varian Inc.), and an Olis DSM 17 ECD spectrophotometer (Olis, Inc.). NMR data were collected using either a JEOL ECA-500 NMR spectrometer operating at 500 MHz for 1 H and 125 MHz for 13 C, or a JEOL ECS-400 NMR spectrometer operating at 400 MHz for 1 H and 100 MHz for 13 C and equipped with a high sensitivity JEOL Royal probe and a 24-slot autosampler (both from JEOL Ltd.), or an Agilent 700 MHz NMR spectrometer (Agilent Technologies), equipped with a cryoprope, operating at 700 MHz for 1 H and 175 MHz for 13 C. Residual solvent signals were utilized for referencing. HRMS utilized a Thermo LTQ Orbitrap XL mass spectrometer equipped with an electrospray ionization source (Thermo Fisher Scientific). A Waters Acquity UPLC system (Waters Corp.) utilizing a Waters BEH C18 column (1.7 μm; 50 × 2.1 mm) was used to evaluate the purity of the isolated compounds with data collected and analyzed using Empower 3 software. Phenomenex Gemini-NX C18 analytical (5 μm; 250 × 4.6 mm), preparative (5 μm; 250 × 21.2 mm), and semipreparative (5 μm; 250 × 10.0 mm) columns (all from Phenomenex) were used on a Varian Prostar HPLC system equipped with ProStar 210 pumps and a Prostar 335 photodiode array detector (PDA), with data collected and analyzed using Galaxie Chromatography Workstation software (version 1.9.3.2, Varian Inc.). Flash chromatography was performed on a Teledyne ISCO CombiFlash Rf 200 using Silica Gold columns (both from Teledyne Isco) and monitored by UV and evaporative light-scattering detectors. Single crystal X-ray diffraction data were collected using a Bruker APEX CCD diffractometer (Mo Kα radiation, graphite monochromator). The crystallographic images were generated using CrystalMaker (CrystalMaker Software). All other reagents and solvents were obtained from Fisher Scientific and were used without further purification.
Fungal strains isolation and identification
Fungal strains G100 and G102 were isolated from conidia that were found on samples of submerged wood collected from Lake Brandt (36°10′01.0″N 79°50′18.0″W) in Greensboro, North Carolina, USA in October 2011. Collecting methods and culturing conditions utilized protocols outlined previously. 32, 33, 34 Identifications were based on observation of micromorphological characters using an Olympus microscope (BX53) equipped with an Olympus DP25 camera. Molecular sequence data were obtained from internal transcribed spacer regions 1 & 2 and 5.8S nrDNA (ITS). 21 DNA extraction, PCR amplification, and sequencing were performed using previously described methods. 1, 2, 35 To obtain identification via sequence comparisons, the ITS region was BLAST searched against both GenBank and the UNITE databases. 36 Results from BLAST search suggested sequence similarities between G100 and G102 to certain taxa within the order Pleosporales, Dothideomycetes, Ascomycota. G100 showed similarity (94%) to Clohesyomyces aquaticus, 37, 38 whereas, G102 showed similarity (98%) to Clohesyomyces sp. (MAFF 239218; GenBank: JQ435791). Interestingly, G100 was also morphologically identical to Clohesyomyces aquaticus (Fig. S20 ). The sequences with high homology were downloaded and analyzed using Maximum Likelihood 39 to phylogenetically evaluate the evolutionary affinities of the two isolates (G100, and G102). Based on the results of morphology, BLAST search, and phylogenetic analysis of the ITS region, strain G100 was identified as Clohesyomyces aquaticus, while strain G102 was identified as having phylogenetic affinities to Clohesyomyces sp. (MAFF 239218; GenBank: JQ435791) (Fig. S19) . The ITS sequences for both strains were deposited in the GenBank (G100: KM589855; G102: KU926856). Voucher cultures of strain G100 and G102 are maintained in the Department of Chemistry and Biochemistry culture collection at the University of North Carolina at Greensboro.
Fermentation, extraction and isolation
Extraction and fractionation of four fungal cultures of G100 and three fungal cultures of G102 grown on rice, each weighing about 25 g, were performed as described previously. 3 The organic defatted extract of G102 fungal culture (240 mg) was dissolved in CHCl3, adsorbed onto Celite 545, and fractionated via normal-phase flash chromatography using a gradient solvent system of hexane-CHCl3-MeOH at a 30 mL/min flow rate and 61.0 column volumes over 34.1 min to afford five fractions. Fraction 2 (103.0 mg) was subjected to preparative HPLC using a gradient system of 40:60-80:20 of CH3CN-H2O (0.1% formic acid) over 15 min at a flow rate of 21.24 mL/min to yield 6 sub-fractions. Sub-fractions 2 and 3 yielded compounds 1 (27.8 mg) and 14 (2.3 mg), which eluted at 11.2 min and 12.7 min, respectively. Fraction 3 (26.8 mg) was subjected to preparative HPLC using a gradient system of 30:70-80:20 of CH3CN-H2O (0.1% formic acid) over 30 min at a flow rate of 21.24 mL/min to yield 10 sub-fractions. Sub-fractions 1, 2, 3, 4, 5, and 7 yielded compounds 5 (0.5 mg), 15 (0.6 mg), 16 (1.3 mg), 7 (2.8 mg), 10 (0.7 mg), and 13 (7.4 mg), which eluted at 5.5 min, 6.6 min, 8.2 min, 11.0 min, 13.5 min, and 25.7 min, respectively. Compounds 7 (2.8 mg) and 16 (1.3 mg) were subjected to further purification using semipreparative HPLC using a gradient system of 40:60-60:40 of CH3OH-H2O (0.1% formic acid) over 15 min at a flow rate of 4.72 mL/min to yield compounds 7 (0.7 mg) and 16 (1.0 mg), which eluted at 18.5 min and 12.6 min, respectively. Fraction 4 (37.5 mg) was subjected to preparative HPLC using a gradient system of 20:80-80:20 of CH3CN-H2O (0.1% formic acid) over 30 min at a flow rate of 21.24 mL/min to yield 12 sub-fractions. Subfractions 1, 2, 6, 7, and 8 yielded compounds 8 (2.4 mg), 11 (1.0 mg), 12 (0.9 mg), 6 (1.2 mg), and 4 (1.7 mg), which eluted at 4.3 min, 5.0 min, 13.3 min, 15.5 min, and 16.5 min, respectively. Compound 11 (1.0 mg) was subjected to further purification using semipreparative HPLC using a gradient system of 20:80 to 40:60 of CH3OH-H2O (0.1% formic acid) over 15 min at a flow rate of 4.72 mL/min to yield compound 11 (0.5 mg), which eluted at 13.0 min. Sub-fractions 3 (7.4 mg) and 4 (2.0 mg) were combined and subjected to preparative HPLC using an isocratic system of 20:80 of CH3CN-H2O (0.1% formic acid) at a flow rate of 21.24 mL/min to yield compounds 3 (0.7 mg), 9 (4.7 mg), and 2 (2.0 mg), which eluted at 43.0 min, 46.5 min, and 53.5 min, respectively. Compound 2 (2.0 mg) was subjected to further purification using semipreparative HPLC using an isocratic system of 25:75 of CH3OH-H2O (0.1% formic acid) at a flow rate of 4.72 mL/min to yield compound 2(0.8 mg), which eluted at 38.0 min. Fraction 5 (63.9 mg) was subjected to preparative HPLC using a gradient system of 20:80-80:20 of CH3CN-H2O (0.1% formic acid) over 30 min at a flow rate of 21.24 mL/min to yield 9 subfractions. Sub-fractions 1, 3, and 5 yielded compounds 9 (2.2 mg), 17 (1.4 mg), and 18 (1.6 mg), which eluted at 7.9 min, 22.4 min, 24.3 min, respectively.
In an analogous manner, the organic defatted extract of G100 fungal culture (170 mg) was dissolved in CHCl3, adsorbed onto Celite 545, and fractionated via normal-phase flash chromatography using a gradient solvent system of hexane-CHCl3-MeOH at a 30 mL/min flow rate and 61.0 column volumes over 34.1 min to afford five fractions. Extensive preparative and semipreparative HPLC purifications of fractions 2-5 yielded compounds 1 (6.1 mg), 4 (0.8 mg), 6 (2.0 mg), 7 (1.7 mg), 8 (2.5 mg), 17 (4.6 mg), and 18 (10.7 mg). 1 H NMR (CDCl3, 500 MHz) and 13 C NMR (CDCl3, 125 MHz), see Table 1, Table 2 1 H NMR (CDCl3, 500 MHz) and 13 C NMR (CDCl3, 125 MHz), see Table 1 , Table 2 1 H NMR (CDCl3, 500 MHz) and 13 C NMR (CDCl3, 125 MHz), see Table 1, Table 2 ; HRESIMS m/z 213.0756 [M+H] + (calcd for C10H13O5 213.0758).
(±)-7-Hyrdoxypyrenocine M (9)
Colorless solid; UV (MeOH) λmax (log ε) 283 (3.36), 213 (3.33) nm; 1 H NMR (CDCl3, 500 MHz) and 13 C NMR (CDCl3, 125 MHz), see Table 2 , Table 3 ; HRESIMS m/z 243.1229 [M+H] + (calcd for C12H19O5 243.1227).
(±)-Pyrenocine Q (10)
Colorless solid; UV (MeOH) λmax (log ε) 246 (3.25), 212 (3.08) nm; 1 H NMR (CDCl3, 500 MHz) and 13 C NMR (CDCl3, 175 MHz), see Table 2 , Table 3 ; HRESIMS m/z 227.1275 [M+H] + (calcd for C12H19O4 227.1278).
Pyrenocine R (11)
Colorless solid; UV (MeOH) λmax (log ε) 284 (2.93), 211 (3.04) nm; 1 H NMR (CDCl3, 500 MHz) and 13 C NMR (CDCl3, 125 MHz), see Table 2 , Table S2 .
Bioassay methods
Pth1 from Escherichia coli, Salmonella typhimurium and Pseudomonas aeruginosa was expressed and purified as described previously. 40, 41 Inhibition was determined using established procedures. 28, 30 Briefly quantification of bulk peptidyl-tRNA cleavage to free tRNA was quantified using electrophoretic separation via acid-urea gel to determine inhibitory activity of compounds under study. Figure S1 cont. UPLC chromatograms of compounds 1-18 (ELSD detection), demonstarting >95% purity. All data were acquired via an Acquity UPLC system with a BEH C18 (1.7 μm 2.1 × 50 mm) column and a CH3CN-H2O gradient that incresaed linearly from 20 to 100% CH3CN over 4.5 min. (ppm)  168  160  152  144  136  128  120  112  104  96  88  80  72  64  56  48  40  32  24 Normalized Intensity Figure S11 . 1 Figure S13 . 1 
